4//SEC Filing
Donenberg Phillip B. 4
Accession 0001415889-24-015039
CIK 0001806310other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:18 PM ET
Size
7.4 KB
Accession
0001415889-24-015039
Insider Transaction Report
Form 4
DONENBERG PHILIP B
Director
Transactions
- Award
Common Stock
2024-05-29+49,220→ 163,331 total - Award
Stock Option (right to buy)
2024-05-29+98,440→ 98,440 totalExercise: $3.17Exp: 2034-05-29→ Common Stock (98,440 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001238120
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:18 PM ET
- Size
- 7.4 KB